Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
Not yet recruiting · NCT07814001 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07814001 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
| The Lymphoma Academic Research Organisation | 20 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Léon Berard | Lyon | France | 4 |
| CHRU Nancy - Hopital Brabois | Vandœuvre-lès-Nancy | France | 1 |
| CHU de Bordeaux - Hopital Haut-Leveque | Pessac | France | 2 |
| CHU de Lille - Hopital Claude Huriez | Lille | France | 5 |
| CHU de Limoges - Hopital Dupuytren | Limoges | France | 2 |
| CHU de Montpellier | Montpellier | France | 1 |
| Chu de Nantes | Nantes | France | 72 |
| CHU de Poitiers - Hopital de la Miletrie | Poitiers | France | 1 |
| Chu Dijon Bourgogne | Dijon | France | 69 |
| CHU Lyon Sud | Pierre-Bénite | France | 13 |
| CHU Pontchaillou | Rennes | France | 8 |
| Hopital Henri Mondor | Créteil | France | 23 |
| Hopital Necker | Paris | France | 7 |
| Institut Paoli Calmettes | Marseille | France | 38 |
| IUCT Oncopole | Toulouse | France | 12 |